On one hand, I would point out the 'beta testing' is the testing already ongoing, and that once that's concluded there's a 99.99999999% chance it's safe.
And the other two trials to report have so far shown no sign of any fuckups at all, nor is there any belief there have been any outside of AstraZeneca. And the the AstraZeneca one still shows it works to some degree, with the actual effectiveness the thing they need to pin down with further analysis.Waiting, but not due to side effects but due to efficacy.
Already the Astra Zenica trials have been shown to be so full of fuckups that they're expanding and re-running them.
Yep. The chances of having a side effect are none. The biggest side effect you may get is a sore arm after the shot.Give it to me now. Can't believe the amount of anti-vaxxers we have in era.
And the other two trials to report have so far shown no sign of any fuckups at all, nor is there any belief there have been any outside of AstraZeneca. And the the AstraZeneca one still shows it works to some degree, with the actual effectiveness the thing they need to pin down with further analysis.
Wait, so two jabs, 90% is still not good enough for you?
Let's be completely honest with people getting the vaccine, because they do need to come back a second time. Headache, muscle pain and fatigue are the most common side effect sited with Moderna, and similar with Pfizer. This needs to be communicated honestly to the people taking the vaccines so they are prepared, and so they know they are not experiencing something rare, everything is going fine and they shouldn't be scared of the second shot. Clear and honest communication is the only weapon we have against anti-vaxxers. This might also mean that for hospital staff, this is ideally planned on their last day of work and not in the middle of a work week for instance so as not to impact service and give people time to actually rest the day after.Yep. The chances of having a side effect are none. The biggest side effect you may get is a sore arm after the shot.